Article
A functional polymorphism in the promoter region of TLR3 is associated with susceptibility to end-stage renal disease.
American journal of nephrology - 1 Jan 2014
Yang Hsin-Yi, Huang Shih-Ming, Lu Kuo-Cheng, Wu Chia-Chao, Kang Chi-Yu, Lin Yuh-Feng, Lin Chin, Lin Fu-Huang, Kao Sen-Yeong, Su Sui-Lung
Abstract excerpt
BACKGROUND/AIMS: End-stage renal disease (ESRD) is simultaneously associated with immune activation, systemic inflammation and immune deficiency. Toll-like receptor 3 (TLR3), a receptor for viral double-stranded RNA, is involved in immune cell activation in renal diseases and may contribute to chronic inflammatory disease progression. To date, effects of TLR3 polymorphisms on ESRD remain unknown. Therefore, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
